Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition
(Sprache: Englisch)
This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 59.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition “
Klappentext zu „Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition “
This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
Inhaltsverzeichnis zu „Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition “
Introduction and background biology.- HER2 testing.- HER2-positive breast cancer: neoadjuvant and adjuvant therapy.- HER2-positive metastatic breast cancer: first-line treatment.- HER2-positive metastatic breast cancer: second-line treatment.- Emerging targeted agents for HER2-positive breast cancer.
Autoren-Porträt von Ricardo Alvarez, Javier Cortes, Mary Falzon, Luca Gianni, Nadia Harbeck, Martine Piccart
Ricardo Alvarez is Director of Clinical Research and Breast Cancer Specialist at Cancer Treatment Centers of America in Atlanta, Georgia.Javier Cortes is Deputy Director of the Breast Cancer Program, Head of the Breast Cancer and Melanoma Group in the Oncology Department of Vall d'Hebron University Hospital in Barcelona, Spain.
Mary Falzon is Consultant histo/cytopathologist and Divisional Clinical Director for University College London Hospitals in London, UK.
Michael Gandy is lead biomedical scientist and clinical services manager at University College London- Advanced Diagnostics in London, UK.
Luca Gianni is the Director of the Department of Medical Oncology at the Hospital San Raffaele in Milan, Italy.
Nadia Harbeck is Head of the Breast Center at the University of Munich and heads the Oncological Therapy and Clinical Trials Unit in Obstetrics and Gynecology in Munich,Germany.
Martine Piccart is Professor of Oncology at the Université Libre de Bruxelles and Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium.
Bibliographische Angaben
- Autoren: Ricardo Alvarez , Javier Cortes , Mary Falzon , Luca Gianni , Nadia Harbeck , Martine Piccart
- 2016, 2. Aufl., XI, 110 Seiten, 16 farbige Abbildungen, Masse: 12,7 x 20,3 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 331928214X
- ISBN-13: 9783319282145
- Erscheinungsdatum: 27.05.2016
Sprache:
Englisch
Kommentar zu "Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition"
0 Gebrauchte Artikel zu „Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Handbook of HER2-Targeted Agents in Breast Cancer, Second Edition".
Kommentar verfassen